SEROQUEL XR

LOE Approaching

quetiapine fumarate

NDAORALTABLET, EXTENDED RELEASE
Approved
Nov 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Clinical Trials (5)

NCT01256177Phase 3Completed

Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression

Started Dec 2010
361 enrolled
Bipolar Depression
NCT01254721Phase 4Terminated

A Comparison of the Effectiveness of Seroquel XR and Seroquel XR Plus Lithium in Patients With Acute Bipolar Mania: An Open-label, Randomized, Parallel Groups, Rater-blinded, 4 Week, Multicenter, Comparative,Study

Started Dec 2010
131 enrolled
Acute Bipolar Mania
NCT01213836Phase 4Completed

Compare the Effect on Cognitive Functioning of Two Formulations of Seroquel, Seroquel XR and IR in Patients With Stable Schizophrenia

Started Nov 2010
75 enrolled
Schizophrenia
NCT01212575N/ACompleted

A Retrospective NIS to Evaluate the Use of Seroquel XR and IR in the Clinical Practice of Outpatients With Schizophrenia

Started Oct 2010
186 enrolled
Schizophrenia
NCT01202617N/ACompleted

Seroquel XR in the Long Term Treatment of Schizophrenia

Started Sep 2010
1,606 enrolled
Relapse in Schizophrenia